SCIENTIFIC EVENTS

Nathalie is the invited keynote speaker of the Departement de Biochimie et Médecine Moléculaire - Université de Montréal
December 2016

 

The CRCHUM symposium on research priorities toward a cure in chronic viral infectious diseases: from pathogen sensing to eradication

Keynote speakers: Dr. Sharon Lewin, Melbourne & Dr. Adolfo Garcia-Sastre, NY

Organisators: Drs. Nathalie Grandvaux & Petronela Ancuta

April 24th 2015

 

Symposium CRCHUM 24 avril 2015-(VF) - copie.jpg
Symposium CRCHUM 24 avril 2015-(VF) - copie.jpg

press to zoom
Alexa is presenting her data
Alexa is presenting her data

press to zoom
Celabration time!
Celabration time!

press to zoom
Symposium CRCHUM 24 avril 2015-(VF) - copie.jpg
Symposium CRCHUM 24 avril 2015-(VF) - copie.jpg

press to zoom
1/6
Nathalie Grandvaux is speaking at the CRCHUM conferences about the role of ROS in the antiviral response

March 2015

 

 

THE LAB MOVES TO THE NEW CRCHUM

December, 2013

 

We are finally moving to the new facilities, state-of the art building regrouping basic and clinical researchers in  Immuno-inflammation-infection, Neuroscience, Cancer&  Cardio-metabolic research.

Thanks to Stefany, we will be well organized!

IMG_0084.JPG
IMG_0084.JPG

press to zoom
IMG_0083_edited.JPG
IMG_0083_edited.JPG

press to zoom
IMG_0124_edited.JPG
IMG_0124_edited.JPG

press to zoom
IMG_0084.JPG
IMG_0084.JPG

press to zoom
1/9
1415282_492606790837894_114182067_o.jpg
1415282_492606790837894_114182067_o.jpg

press to zoom
1400178_492599594171947_1059083676_o.jpg
1400178_492599594171947_1059083676_o.jpg

press to zoom
1403008_492593367505903_1159965165_o.jpg
1403008_492593367505903_1159965165_o.jpg

press to zoom
1415282_492606790837894_114182067_o.jpg
1415282_492606790837894_114182067_o.jpg

press to zoom
1/5
Dr. Jules Hoffmann was the guest of the annual CRCHUM "Protecting health -mitigating risk and danger"

October 2013

 

Dr. Hofmann, recipient of the Nobel Prize, talked about his research on innate immunity.

N. Grandvaux talked about "Innate Immune Antiviral Response – Impact on Long-term Pathogenicity"